4.3 Article

Time-dependent effect of REV-ERBα agonist SR9009 on nonalcoholic steatohepatitis and gut microbiota in mice

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Is it time for chronopharmacology in NASH?

Thomas Marjot et al.

Summary: Liver homeostasis is influenced by the circadian clock. Disruption of the clock has been implicated in metabolic dysfunction like NAFL and NASH. Although current NASH drug candidates target pathways under circadian control, little consideration has been given to chronopharmacology in NASH.

JOURNAL OF HEPATOLOGY (2022)

Article Food Science & Technology

Bifidobacterium animalis subsp. lactis lkm512 Attenuates Obesity-Associated Inflammation and Insulin Resistance Through the Modification of Gut Microbiota in High-Fat Diet-Induced Obese Mice

Lingyan Ma et al.

Summary: The longevity-promoting probiotic strain LKM512 shows potential in improving hepatic lipid accumulation, reducing inflammation, and enhancing insulin sensitivity in high-fat diet-induced obese mice. It also has an impact on the composition and function of gut microbiota in these mice.

MOLECULAR NUTRITION & FOOD RESEARCH (2022)

Review Chemistry, Multidisciplinary

The role of REV-ERB in NASH

Kristine Griffett et al.

Summary: REV-ERBs are atypical nuclear receptors that function as ligand-regulated transcriptional repressors. They regulate key physiological processes involved in non-alcoholic steatohepatitis (NASH), including metabolism and inflammatory pathways.

ACTA PHARMACOLOGICA SINICA (2022)

Review Gastroenterology & Hepatology

Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms

Patrice D. Cani et al.

Summary: This article reviews the discovery of Akkermansia muciniphila and its association with health and disease. Studies have shown that A. muciniphila can improve health through various mechanisms and comparisons are made with other next-generation beneficial microorganisms.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Cell Biology

The nuclear receptor REV-ERBα is implicated in the alteration of β-cell autophagy and survival under diabetogenic conditions

Matthew R. Brown et al.

Summary: This study reveals a previously unexplored causative relationship between REV-ERB alpha expression, inhibition of autophagy, and beta-cell failure in type 2 diabetes mellitus.

CELL DEATH & DISEASE (2022)

Article Gastroenterology & Hepatology

Current therapies and new developments in NASH

Jean-Francois Dufour et al.

Summary: Non-alcoholic steatohepatitis is becoming the most important etiology for advanced liver disease. Significant progress has been made in this field in recent years, with better understanding of the complexity of the pathophysiology of NASH and testing of multiple non-invasive biomarkers. The importance of lifestyles has been recognized and clinical trials of several drugs are underway. This review addresses the challenges faced by healthcare professionals in managing NASH patients.
Article Nutrition & Dietetics

Compound dietary fiber and high-grade protein diet improves glycemic control and ameliorates diabetes and its comorbidities through remodeling the gut microbiota in mice

Yinhua Ni et al.

Summary: Dietary intervention with a low glycemic index and full nutritional support, such as the novel compound dietary fiber and high-grade protein diet (CFP), can effectively improve glycemic control, insulin resistance, and diabetes-related metabolic syndromes. CFP treatment enhances gut barrier function and alters gut microbiota composition and function, leading to a wider range of protection against diabetes compared to liraglutide.

FRONTIERS IN NUTRITION (2022)

Review Biochemistry & Molecular Biology

Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota

Yinhua Ni et al.

Summary: The role of gut-kidney crosstalk in the progression of diabetic nephropathy is of increasing concern. Renal dysfunction increases circulating uremic toxins and affects the gut microbiota, while intestinal dysbiosis destroys the epithelial barrier, leading to increased exposure to endotoxins, and exacerbating kidney damage through systemic inflammation. Dietary interventions and novel diabetic agents targeting the gut microbiota may be potential therapies for diabetic nephropathy.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2022)

Review Cell Biology

Gut-liver axis: Pathophysiological concepts and clinical implications

Herbert Tilg et al.

Summary: Bidirectional crosstalk between the gut and liver plays a crucial role in regulating gastrointestinal health and disease. Nutrients, microbial antigens, metabolites, and bile acids regulate metabolism and immune responses in the gut and liver, which reciprocally shape the structure and function of the microbial community. Perturbation of this host-microbe interaction is observed in various liver diseases and is exacerbated by impaired intestinal barrier, contributing to hepatic inflammation and disease progression.

CELL METABOLISM (2022)

Review Biochemistry & Molecular Biology

Role of Circadian Transcription Factor Rev-Erb in Metabolism and Tissue Fibrosis

Ghulam Shere Raza et al.

Summary: This review summarizes the importance of Rev-Erb in extracellular matrix remodeling and tissue fibrosis, and highlights the beneficial effects of Rev-Erb activation in the heart, lung, liver, and adipose tissue.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Nutrition & Dietetics

The Effect of Short-Term Consumption of Lactic Acid Bacteria on the Gut Microbiota in Obese People

Inna Burakova et al.

Summary: Obesity is causing many concomitant diseases, and new strategies for treatment and prevention are being developed using probiotics to modulate the gut microbiota. A study found an increase in Actinobacteriota and a decrease in Bacteroidota in obese patients taking lactic acid bacteria. Beneficial groups like Bifidobacterium and Lactococcus increased, while harmful groups like Faecalibacterium and Clostridium decreased. Modulating the gut microbiota with lactic acid bacteria may be a way to treat obesity.

NUTRIENTS (2022)

Article Endocrinology & Metabolism

Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeability

Yinhua Ni et al.

Summary: The study found that Rev-erb alpha decreased in the intestines of mice with high cholesterol, high fat diet-induced NASH, and by activating autophagy and reducing apoptotic signaling of epithelial cells, it protected against increased intestinal permeability. This led to improvements in hepatic lipid accumulation, insulin resistance, inflammation, and fibrosis in mice with NASH.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Article Pharmacology & Pharmacy

REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome

Huiling Hong et al.

Summary: The circadian clock regulates inflammatory responses and the production of cytokines, with REV-ERB alpha and BMAL1 playing key roles in this process. Pharmacological activation of REV-ERB alpha can suppress inflammation, particularly in the NLRP3 inflammasome pathway, dependent on BMAL1 expression.

BIOCHEMICAL PHARMACOLOGY (2021)

Review Medical Laboratory Technology

The circadian clock and inflammation: A new insight

Hui Xu et al.

Summary: The circadian clock influences physiological processes, including inflammation, and can physically interact with key inflammatory pathways. Inflammation, in turn, can disrupt the circadian rhythm, leading to exacerbated inflammatory responses and tissue damage. This review focuses on the interactions between core circadian clock proteins and inflammatory factors, providing insight into the potential mechanisms behind pathological rhythms observed in inflammatory conditions.

CLINICA CHIMICA ACTA (2021)

Review Biotechnology & Applied Microbiology

Circadian rhythm as a therapeutic target

Wei Ruan et al.

Summary: The circadian clock plays a crucial role in integrating external environmental changes and internal physiology, providing temporal precision and robust adaptation to the environment. Disruption of circadian rhythms can lead to adverse health consequences, but there is still an underappreciation of how to take advantage of biological timing for health benefits. Promising progress in research and clinical applications should drive efforts towards a new era of circadian medicine.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Nutrition & Dietetics

Olive Fruit Extracts Supplement Improve Antioxidant Capacity via Altering Colonic Microbiota Composition in Mice

Mengyu Wang et al.

Summary: In summary, the study demonstrated that treatment with 100 mg/kg body weight polyphenol-rich OE could significantly enhance the antioxidant capacity in mice by increasing serum antioxidative enzyme activities and altering the colonic microbiota community.

FRONTIERS IN NUTRITION (2021)

Article Biochemistry & Molecular Biology

The microbiota coordinates diurnal rhythms in innate immunity with the circadian clock

John F. Brooks et al.

Summary: The study found that the intestinal microbiota generates diurnal rhythms in innate immunity that synchronize with feeding rhythms to anticipate microbial exposure. This synchronization activates an immunological circuit triggering oscillations in epithelial STAT3 expression and activation that produce rhythmic antimicrobial protein expression, causing resistance to bacterial infection to vary across the day-night cycle.
Article Agriculture, Multidisciplinary

Flavonoids from Whole-Grain Oat Alleviated High-Fat Diet-Induced Hyperlipidemia via Regulating Bile Acid Metabolism and Gut Microbiota in Mice

Ruiqian Duan et al.

Summary: Whole-grain oat flavonoids can improve hyperlipidemia induced by high-fat diet by regulating lipid metabolism, promoting bile acid synthesis, and enhancing the efflux of fat through the FXR pathway. Additionally, they can significantly alter the composition of gut microbiota, reducing harmful bacteria and increasing beneficial bacteria.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)

Article Medicine, Research & Experimental

The role of SHP/REV-ERBα/CYP4A axis in the pathogenesis of alcohol-associated liver disease

Zhihong Yang et al.

Summary: This study identified a role for the SHP/REV-ERB alpha/CYP4A axis in the pathogenesis of ALD, highlighting REV-ERB alpha or CYP4A as potential therapeutic targets for ALD.

JCI INSIGHT (2021)

Article Biochemistry & Molecular Biology

Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice

Yinhua Ni et al.

FREE RADICAL BIOLOGY AND MEDICINE (2020)

Article Gastroenterology & Hepatology

Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease

Anand R. Saran et al.

GASTROENTEROLOGY (2020)

Review Endocrinology & Metabolism

Intersection of the Gut Microbiome and Circadian Rhythms in Metabolism

Katya Frazier et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)

Review Food Science & Technology

The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non-Alcoholic Fatty Liver Disease

Yinhua Ni et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2020)

Review Gastroenterology & Hepatology

Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis

Toon J. I. De Munck et al.

LIVER INTERNATIONAL (2020)

Article Multidisciplinary Sciences

REV-ERB agonism improves liver pathology in a mouse model of NASH

Kristine Griffett et al.

PLOS ONE (2020)

Review Multidisciplinary Sciences

Fibrosis: from mechanisms to medicines

Neil C. Henderson et al.

NATURE (2020)

Article Gastroenterology & Hepatology

Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice

Lingyan Ma et al.

GUT MICROBES (2020)

Article Agriculture, Multidisciplinary

Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota

Yizhe Cui et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)

Article Endocrinology & Metabolism

High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine

M. R. Panasevich et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)

Article Medicine, Research & Experimental

Circadian clock component REV-ERBα controls homeostatic regulation of pulmonary inflammation

Marie Pariollaud et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Review Medicine, General & Internal

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

Anna M. Diehl et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Oncology

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis

Nicole M. Kettner et al.

CANCER CELL (2016)

Review Gastroenterology & Hepatology

Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations

Zaki A. Sherif et al.

DIGESTIVE DISEASES AND SCIENCES (2016)

Article Biochemistry & Molecular Biology

Oxidative Stress and Inflammation Modulate Rev-erbα Signaling in the Neonatal Lung and Affect Circadian Rhythmicity

Guang Yang et al.

ANTIOXIDANTS & REDOX SIGNALING (2014)

Article Gastroenterology & Hepatology

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice

Tiphaine Le Roy et al.

Review Gastroenterology & Hepatology

Bile-acid-induced cell injury and protection

Maria J. Perez et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2009)

Article Biochemistry & Molecular Biology

REV-ERBα Participates in Circadian SREBP Signaling and Bile Acid Homeostasis

Gwendal Le Martelot et al.

PLOS BIOLOGY (2009)

Article Multidisciplinary Sciences

Obesity and metabolic syndrome in circadian Clock mutant mice

FW Turek et al.

SCIENCE (2005)